Growth Metrics

Armata Pharmaceuticals (ARMP) Asset Utilization Ratio (2016 - 2020)

Quarterly results put Asset Utilization Ratio at 0.0 for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was 0.0 (changed N/A YoY), and the annual figure for FY2017 was 0.01, down 25.03%.

Armata Pharmaceuticals has reported Asset Utilization Ratio over the past 5 years, most recently at 0.0 for Q2 2020.

  • Asset Utilization Ratio reached 0.0 in Q2 2020 per ARMP's latest filing, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q2 2016 and bottomed at 0.0 in Q2 2020.
  • Median Asset Utilization Ratio over the past 3 years was 0.01 (2017), compared with a mean of 0.01.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 53.3% in 2016 before it plummeted 55.98% in 2017.
  • Over 3 years, Asset Utilization Ratio stood at 0.01 in 2016, then decreased by 21.57% to 0.01 in 2017, then crashed by 72.9% to 0.0 in 2020.
  • Business Quant data shows Asset Utilization Ratio for ARMP at 0.0 in Q2 2020, 0.01 in Q4 2017, and 0.01 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 0.60
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 0.47
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 0.37
8 Evaxion A 65.12 Bn 65.10 Bn - 0.29
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 0.85
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 0.00
Dec 31, 2017 0.01
Sep 30, 2017 0.01
Jun 30, 2017 0.01
Mar 31, 2017 0.01
Dec 31, 2016 0.01
Sep 30, 2016 0.01
Jun 30, 2016 0.02